167 related articles for article (PubMed ID: 33478477)
1. The effect of pay-for-performance program on infection events and mortality rate in diabetic patients: a nationwide population-based cohort study.
Wu YF; Chen MY; Chen TH; Wang PC; Peng YS; Lin MS
BMC Health Serv Res; 2021 Jan; 21(1):78. PubMed ID: 33478477
[TBL] [Abstract][Full Text] [Related]
2. A nationwide cohort investigation on pay-for-performance and major adverse limb events in patients with diabetes.
Lu CW; Wu YF; Chen TH; Chung CM; Lin CL; Lin YS; Chen MY; Yang YH; Lin MS
Prev Med; 2021 Dec; 153():106787. PubMed ID: 34506818
[TBL] [Abstract][Full Text] [Related]
3. The effect of pay for performance on risk incidence of hip fracture in type 2 diabetic patients: a nationwide population-based cohort study.
Lee YH; Kung PT; Kuo WY; Kao SL; Tsai WC
Medicine (Baltimore); 2020 Mar; 99(12):e19592. PubMed ID: 32195973
[TBL] [Abstract][Full Text] [Related]
4. Impact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study.
Chen YC; Lee CT; Lin BJ; Chang YY; Shi HY
Medicine (Baltimore); 2016 Jul; 95(27):e4197. PubMed ID: 27399144
[TBL] [Abstract][Full Text] [Related]
5. Does the pay-for-performance programme reduce the emergency department visits for hypoglycaemia in type 2 diabetic patients?
Yu HC; Tsai WC; Kung PT
Health Policy Plan; 2014 Sep; 29(6):732-41. PubMed ID: 23894069
[TBL] [Abstract][Full Text] [Related]
6. The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study.
Hsieh HM; Lin TH; Lee IC; Huang CJ; Shin SJ; Chiu HC
Prev Med; 2016 Apr; 85():53-59. PubMed ID: 26740347
[TBL] [Abstract][Full Text] [Related]
7. A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan.
Hsieh HM; Chiu HC; Lin YT; Shin SJ
Int J Qual Health Care; 2017 Aug; 29(4):512-520. PubMed ID: 28531317
[TBL] [Abstract][Full Text] [Related]
8. A Diabetes Pay-for-Performance Program and Risks of Cancer Incidence and Death in Patients With Type 2 Diabetes in Taiwan.
Hsieh HM; He JS; Shin SJ; Chiu HC; Lee CT
Prev Chronic Dis; 2017 Oct; 14():E88. PubMed ID: 28981404
[TBL] [Abstract][Full Text] [Related]
9. Pay-for-performance programmes reduce stroke risks in patients with type 2 diabetes: a national cohort study.
Chou CW; Kung PT; Chou WY; Tsai WC
BMJ Open; 2019 Oct; 9(10):e026626. PubMed ID: 31619415
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan.
Cheng SL; Li YR; Huang N; Yu CJ; Wang HC; Lin MC; Chiu KC; Hsu WH; Chen CZ; Sheu CC; Perng DW; Lin SH; Yang TM; Lin CB; Kor CT; Lin CH
Int J Chron Obstruct Pulmon Dis; 2021; 16():2869-2881. PubMed ID: 34703221
[TBL] [Abstract][Full Text] [Related]
11. Effects of Body Mass Index and Pay-for-Performance Program on Risk of Death in Patients with Type 2 Diabetes: A Nationwide Cohort Study.
Huang HL; Kung CY; Wang SM; Kung PT; Lin YH; Chiu LT; Tsai WC
Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925667
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of the pay-for-performance program for patients with young-onset (20-40 years of age) type 2 diabetes.
Yen FS; Cheng-Chung Wei J; Hung YT; Hsu CC; Hwu CM
Diabetes Res Clin Pract; 2022 Nov; 193():110136. PubMed ID: 36341981
[TBL] [Abstract][Full Text] [Related]
13. Diabetes pay-for-performance program can reduce all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus.
Kung FP; Tsai CF; Lu CL; Huang LC; Lu CH
Medicine (Baltimore); 2020 Feb; 99(7):e19139. PubMed ID: 32049836
[TBL] [Abstract][Full Text] [Related]
14. Adding Pay-for-Performance Program to Routine Care Was Related to a Lower Risk of Depression Among Type 2 Diabetes Patients in Taiwan.
Lian WC; Livneh H; Huang HJ; Lu MC; Guo HR; Tsai TY
Front Public Health; 2021; 9():650452. PubMed ID: 34722429
[No Abstract] [Full Text] [Related]
15. Effects of pay for performance on risk incidence of infection and of revision after total knee arthroplasty in type 2 diabetic patients: A nationwide matched cohort study.
Tsai YS; Kung PT; Ku MC; Wang YH; Tsai WC
PLoS One; 2018; 13(11):e0206797. PubMed ID: 30388167
[TBL] [Abstract][Full Text] [Related]
16. Effect of a Pay-for-Performance Program on Renal Outcomes Among Patients With Early-Stage Chronic Kidney Disease in Taiwan.
Lin MT; Hsu CN; Lee CT; Cheng SH
Int J Health Policy Manag; 2022 Aug; 11(8):1307-1315. PubMed ID: 33906336
[TBL] [Abstract][Full Text] [Related]
17. Factors related to continuing care and interruption of P4P program participation in patients with diabetes.
Yen SM; Kung PT; Sheen YJ; Chiu LT; Xu XC; Tsai WC
Am J Manag Care; 2016 Jan; 22(1):e18-30. PubMed ID: 26799201
[TBL] [Abstract][Full Text] [Related]
18. Pay-for-performance and continuity of care synergistically reduced amputation of lower extremity in patients with diabetes: a population-based cohort study.
Chen YC; Liao YH; Ku LE; Wang JD
BMC Health Serv Res; 2022 Jun; 22(1):748. PubMed ID: 35659668
[TBL] [Abstract][Full Text] [Related]
19. Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?
Tan EC; Pwu RF; Chen DR; Yang MC
Qual Life Res; 2014 Mar; 23(2):687-96. PubMed ID: 23975377
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of a pre-ESRD pay-for-performance programme in advanced chronic kidney disease patients.
Hsieh HM; Lin MY; Chiu YW; Wu PH; Cheng LJ; Jian FS; Hsu CC; Hwang SJ
Nephrol Dial Transplant; 2017 Jul; 32(7):1184-1194. PubMed ID: 28486670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
